IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SR One Capital Management, LP

Q3 2022 Holdings

Filed 2022-11-08 | 4 holdings | $218.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcellx Inc.(ACLX)COMMON STOCK03940C100$103.2K5,500,00747.2%
Design Therapeutics Inc(DSGN)COM25056L103$94.1K5,626,47643.0%
Nkarta Inc.(NKTX)COM65487U108$17.5K1,333,3338.0%
Effector Therapeutics IncCOM28202V108$3.9K6,822,1141.8%